Obstructive Sleep Apnea (OSA) A Daily Nightmare That Can Be Avoided
Abstract
We are living with an explosion of cardiovascular diseases in the modern world. It is known that the quality of life has worsened in the world scenario and the control of risk factors, access to medical services and adherence to the proposed treatments is the great challenge for many countries, and its excellence is a privilege of few. The knowledge of traditional risk factors such as high blood pressure, diabetes, obesity, sedentary lifestyle, increased cholesterol for the development of these diseases is known, but other factors such as sleep apnea still need to be further disseminated. A significant portion of the adult population suffers from this condition, which is considered a new risk factor for the development of cardiovascular diseases and for increasing systemic blood pressure. It is up to scientific departments and public agencies related to human health to disclose ways of suspecting this condition of later formalization of the diagnosis and proper treatment. The anamnesis looking for signs of physical fatigue, lack of concentration, drowsiness, irritability, restless sleep and the presence of snoring, associated with increased neck circumference and increased hematocrit are easy to identify. [1] Obstructive sleep apnea (OSA) should be treated as a serious risk factor for the development of cardiovascular diseases and a more intense approach is necessary.
Keywords:
- sleep, obstructive sleep apnea, cardiovascular disease
References
Duggan JP, Peters AS, Trachiotis GD, Antevil JL. Epidemiology of Coronary Artery Disease. Surg Clin North Am. 2022;102(3):499-516. doi:10.1016/j.suc.2022.01.007 The lack of diagnosis of this disease will negatively impact both the primary and secondary prevention of cardiovascular diseases, becoming = a factor of worsening of the prognosis and inefficiency of the same.
L. Si, J. Zhang, Y. Wang, J. Cao, B. Chen, and H. Guo, “Obstructive sleep apnea and respiratory center regulation abnormality,” Sleep Breath., vol. 25, no. 2, pp. 563–570, Jun. 2021.
F. C. S. G. Cruz et al., “The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic,” Clinics, vol. 76, no. 1, p. e2926, 2021.
S. Chowdhuri et al., “An official american thoracic society research statement: Impact of mild obstructive sleep apnea in adults,” Am. J. Respir. Crit. Care Med., vol. 193, no. 9, pp. e37–e54, 2016.
S. Ryan, “Mechanisms of cardiovascular disease in obstructive sleep apnoea,” J. Thorac. Dis., vol. 10, no. S34, pp. S4201–S4211, Dec. 2018.
J.-B. Martinot, N.-N. Le-Dong, A. Malhotra, and J.-L. Pépin, “Respiratory effort during sleep and prevalent hypertension in obstructive sleep apnoea,” Eur. Respir. J., vol. 61, no. 3, p. 2201486, Mar. 2023.
J. Brown, F. Yazdi, M. Jodari-Karimi, J. G. Owen, and E. Reisin, “Obstructive Sleep Apnea and Hypertension: Updates to a Critical Relationship,” Curr. Hypertens. Rep., vol. 24, no. 6, pp. 173–184, Jun. 2022.
K. Abu, M. L. Khraiche, and J. Amatoury, “Obstructive sleep apnea diagnosis and beyond using portable monitors,” Sleep Med., vol. 113, no. December 2023, pp. 260–274, Jan. 2024.
G. do L. Pinheiro et al., “Validation of an Overnight Wireless High-Resolution Oximeter plus Cloud-Based Algorithm for the Diagnosis of Obstructive Sleep Apnea,” Clinics, vol. 75, no. 9, p. e2414, 2020.
World Health Organization. Cardiovascular Diseases [Internet]. Geneva: World Health Organization; 2022 [cited 2023 Jan]. Available from: https://www.who.int/health-topics/cardiovascular-diseases.
-
Article Viewed: 0
Total Download
##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##